CORC

浏览/检索结果: 共6条,第1-6条 帮助

限定条件    
已选(0)清除 条数/页:   排序方式:
ADALIMUMAB TAPERING WITH COMBINED METHOTREXATE CAN BE EFFECTIVE AS MAINTENANCE THERAPY IN SPA-RELATED UVEITIS (CPCI-S收录) 会议
作者:  Lian, F.[1];  Zhou, J.[1];  Wang, Y.[1];  Xu, H.[1];  Liang, L.[1]
收藏  |  浏览/下载:3/0  |  提交时间:2019/04/11
Efficacy and safety of weekly nab-paclitaxel (nab-P) plus gemcitabine (Gem) in Chinese patients (Pts) with metastatic adenocarcinoma of the p (CPCI-S收录) 会议
作者:  Yu, X.[1];  Shen, L.[2];  Hao, J.[3];  Wang, L.[4];  Pan, H.[5]
收藏  |  浏览/下载:18/0  |  提交时间:2019/04/11
A novel preimplantation genetic diagnosis method for monogenic diseases by targeted sequencing (CPCI-S收录) 会议
作者:  Li, J.[1];  Zhang, X. D.[1];  Xu, Y. W.[2];  Liu, S. J.[1];  Huang, Y. L.[1]
收藏  |  浏览/下载:10/0  |  提交时间:2019/04/11
Dendritic Cells That Highly Express SOCS1 Induce T-Cell Hypo-Responsiveness and Prolong Islet Allograft Survival (CPCI-S收录) 会议
作者:  Chen, M.[1];  Xue, Z.[1];  Zhang, X.[1];  Xu, J.[1];  Wu, L.[1]
收藏  |  浏览/下载:15/0  |  提交时间:2019/04/11
First-line paclitaxel plus carboplatin with/without bevacizumab in recurrent or metastatic nasopharyngeal carcinoma: A multicenter, randomize (CPCI-S收录) 会议
作者:  Zhang, L.[1];  Huang, Y.[1];  Yang, Y.[1];  Ma, S.[1];  Lin, X.[2]
收藏  |  浏览/下载:8/0  |  提交时间:2019/04/11
Prophylactic DLI vs no DLI for refractory acute leukemia undergoing allo-HSCT with sequential intensified conditioning (CPCI-S收录) 会议
作者:  Liu, Q.[1];  Xuan, L.[1];  Fan, Z.[1];  Zhou, H.[1];  Huang, F.[1]
收藏  |  浏览/下载:3/0  |  提交时间:2019/04/11


©版权所有 ©2017 CSpace - Powered by CSpace